SHL Telemedicine (XSWX:SHLTN) ROCE % : -9.79% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is SHL Telemedicine ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SHL Telemedicine's annualized ROCE % for the quarter that ended in Dec. 2023 was -9.79%.

SHL Telemedicine ROCE % Historical Data

The historical data trend for SHL Telemedicine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine ROCE % Chart

SHL Telemedicine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

11.63

0.94

-16.10

2.30

-4.77

SHL Telemedicine Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-26.91	2.87	1.80	0.03	-9.79

SHL Telemedicine ROCE % Calculation

SHL Telemedicine's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4.037	/	( ( (103.205 - 16.606)	+	(97.765 - 15.08) )	/ 2 )
	=	-4.037	/	( (86.599	+	82.685)	/ 2 )
	=	-4.037	/	84.642
	=	-4.77 %

SHL Telemedicine's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-8.094	/	( ( (0 - 0)	+	(97.765 - 15.08) )	/ 1 )
	=	-8.094	/	( ( 0	+	82.685 )	/ 1 )
	=	-8.094	/	82.685
	=	-9.79 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

SHL Telemedicine (XSWX:SHLTN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SHL Telemedicine ROCE % Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SHL Telemedicine (XSWX:SHLTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (XSWX:SHLTN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SHLT:USA

Address

90 Yigal Alon Street, Tel Aviv, ISR, 67891

Website

https://www.shl-telemedicine.com

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.

SHL Telemedicine (XSWX:SHLTN) Headlines

No Headlines